XGN

Exagen Inc.

XGN | $1.4 -2.19% 2.6K

(0.0% 1d) (-10.4% 1m) (-45.7% 1y) (0.0% 2d) (-1.4% 3d) (0.7% 7d) (-76.54% volume)
Earnings Calendar: 2023-11-13
Market Cap: $ 24,130,051
http://www.exagen.com
Sec Filling | Patents | 156 employees

(US) Exagen, Inc. is a commercial-stage diagnostics company. It engages in transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention. The company operates under the Avise brand. Exagen was founded by Waneta C. Tuttle and Cole Harris in 2002 and is headquartered in Vista, CA.

autoimmunity optical brands diagnostics

add to watch list Paper trade email alert is off

Press-releases

Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 Results
Published: 2024-03-18 (Crawled : 12:00) - globenewswire.com
XGN | $1.4 -2.19% 2.6K

Health Services

| -14.81% | O: 17.9% H: 7.33% C: -7.33%
results

Exagen Inc. to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
Published: 2024-03-08 (Crawled : 14:00) - globenewswire.com
XGN | $1.4 -2.19% 2.6K

Health Services

| -29.59% | O: -2.55% H: 3.14% C: -0.52%
sciences

Exagen to Announce Fourth Quarter 2023 and Full-Year Financial Results on March 18, 2024
Published: 2024-03-07 (Crawled : 21:00) - globenewswire.com
XGN | $1.4 -2.19% 2.6K

Health Services

| -29.59% | O: -2.55% H: 3.14% C: -0.52%
financial results

Exagen Inc. to Participate in the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Published: 2024-01-30 (Crawled : 21:00) - globenewswire.com
XGN | $1.4 -2.19% 2.6K

Health Services

| -40.0% | O: -1.74% H: 5.31% C: -4.87%
conference diagnostic life tools

Exagen Inc. Announces Select Preliminary Full-Year 2023 Results and Reaffirms Guidance
Published: 2024-01-07 (Crawled : 20:20) - globenewswire.com
XGN | $1.4 -2.19% 2.6K

Health Services

| Email alert Add to watchlist
results

Exagen Inc. Reports Strong Third Quarter 2023 Results
Published: 2023-11-13 (Crawled : 21:00) - globenewswire.com
XGN | $1.4 -2.19% 2.6K

Health Services

| -5.48% | O: 6.85% H: 17.31% C: 8.97%
results

Exagen Inc. and Johns Hopkins University Announce License Agreement for Novel Patented Lupus Nephritis Biomarkers
Published: 2023-11-09 (Crawled : 21:00) - globenewswire.com
XGN | $1.4 -2.19% 2.6K

Health Services

| -8.0% | O: 2.67% H: 0.0% C: -5.84%
lupus license biomarkers agreement

Exagen Inc. to Participate in the 2023 Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
Published: 2023-11-02 (Crawled : 20:00) - globenewswire.com
XGN | $1.4 -2.19% 2.6K

Health Services

| -17.91% | O: 3.51% H: 0.0% C: -2.87%
services health diagnostics

Exagen to Announce Third Quarter 2023 Financial Results on November 13, 2023
Published: 2023-10-30 (Crawled : 20:00) - globenewswire.com
XGN | $1.4 -2.19% 2.6K

Health Services

| -14.39% | O: 2.36% H: 4.76% C: 3.64%
financial results

Exagen Announces Acceptance of Multiple Abstracts at ACR 2023 Annual Meeting
Published: 2023-09-28 (Crawled : 20:00) - globenewswire.com
XGN | $1.4 -2.19% 2.6K

Health Services

| -43.67% | O: -0.82% H: 4.53% C: -0.41%
meeting

See all